APA

Wheler J. J., Parker B. A., Lee J. J., Atkins J. T., Janku F., Tsimberidou A. M., Zinner R., Subbiah V., Fu S., Schwab R., Moulder S., Valero V., Schwaederle M., Yelensky R., Miller V. A., Stephens M. P. J., Meric-Bernstam F. & Kurzrock R. (20150219). Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. : Oncotarget.

Chicago

Wheler Jennifer J, Parker Barbara A, Lee Jack J, Atkins Johnique T, Janku Filip, Tsimberidou Apostolia M, Zinner Ralph, Subbiah Vivek, Fu Siqing, Schwab Richard, Moulder Stacy, Valero Vicente, Schwaederle Maria, Yelensky Roman, Miller Vincent A, Stephens M Philip J, Meric-Bernstam Funda and Kurzrock Razelle. 20150219. Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. : Oncotarget.

Harvard

Wheler J. J., Parker B. A., Lee J. J., Atkins J. T., Janku F., Tsimberidou A. M., Zinner R., Subbiah V., Fu S., Schwab R., Moulder S., Valero V., Schwaederle M., Yelensky R., Miller V. A., Stephens M. P. J., Meric-Bernstam F. and Kurzrock R. (20150219). Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. : Oncotarget.

MLA

Wheler Jennifer J, Parker Barbara A, Lee Jack J, Atkins Johnique T, Janku Filip, Tsimberidou Apostolia M, Zinner Ralph, Subbiah Vivek, Fu Siqing, Schwab Richard, Moulder Stacy, Valero Vicente, Schwaederle Maria, Yelensky Roman, Miller Vincent A, Stephens M Philip J, Meric-Bernstam Funda and Kurzrock Razelle. Unique molecular signatures as a hallmark of patients with metastatic breast cancer: implications for current treatment paradigms. : Oncotarget. 20150219.